Richard Jefferys
About
In The Last Decade
Richard Jefferys
8 papers receiving 64 citations
Peers
Comparison fields: 5 of 28
- Infectious Diseases 40
- General Health Professions 31
- Virology 18
- Sociology and Political Science 17
- Epidemiology 11
Countries citing papers authored by Richard Jefferys
This map shows the geographic impact of Richard Jefferys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Jefferys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Jefferys more than expected).
Fields of papers citing papers by Richard Jefferys
This network shows the impact of papers produced by Richard Jefferys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Jefferys. The network helps show where Richard Jefferys may publish in the future.
Co-authorship network of co-authors of Richard Jefferys
This figure shows the co-authorship network connecting the top 25 collaborators of Richard Jefferys. A scholar is included among the top collaborators of Richard Jefferys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Jefferys. Richard Jefferys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 22 | |
| 2 | 1 | |
| 3 | HIV, HEPATITIS C VIRUS (HCV), AND TUBERCULOSIS (TB) DRUGS, DIAGNOSTICS, VACCINES, PREVENTIVE TECHNOLOGIES, RESEARCH TOWARD A CURE, AND IMMUNE-BASED AND GENE THERAPIES IN DEVELOPMENT | 1 |
| 4 | 7 | |
| 5 | 2014 PIPELINE REPORT HIV, HEPATITIS C VIRUS (HCV), AND TUBERCULOSIS (TB) DRUGS, DIAGNOSTICS, VACCINES, PREVENTIVE TECHNOLOGIES, RESEARCH TOWARD A CURE, AND IMMUNE-BASED AND GENE THERAPIES IN DEVELOPMENT | 1 |
| 6 | Scanning the scientific horizon. | 0 |
| 7 | 31 | |
| 8 | Errors in Celia Farber's March 2006 article in Harper's Magazine | 3 |
| 9 | 0 | |
| 10 | Gender, ethnicity, and clinical trials. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.